Related Experiment Video
Updated: Oct 26, 2025

CD Spectroscopy to Study DNA-Protein Interactions
Published on: February 10, 2022
DNA binding alters ARv7 dimer interactions
Fatma Özgün1, Zeynep Kaya1, Tunç Morova2
1School of Medicine, Koç University, Istanbul 34450, Turkey.
Abstract:
Androgen receptor (AR) splice variants are proposed to be a potential driver of lethal castration-resistant prostate cancer. AR splice variant 7 (ARv7) is the most commonly observed isoform and strongly correlates with resistance to second-generation anti-androgens. Despite this clinical evidence, the interplay between ARv7 and the highly expressed full-length AR (ARfl) remains unclear. In this work, we show that ARfl/ARv7 heterodimers readily form in the nucleus via an intermolecular N/C interaction that brings the four termini of the proteins in close proximity. Combining fluorescence resonance energy transfer and fluorescence recovery after photobleaching, we demonstrate that these heterodimers undergo conformational changes following DNA binding, indicating dynamic nuclear receptor interaction. Although transcriptionally active, ARv7 can only form short-term interactions with DNA at highly accessible high-occupancy ARfl binding sites. Dimerization with ARfl does not affect ARv7 binding dynamics, suggesting that DNA binding occupancy is determined by the individual protein monomers and not the homodimer or heterodimer complex. Overall, these biophysical studies reveal detailed properties of ARv7 dynamics as both a homodimer or heterodimer with ARfl.
Insights
Androgen receptor splice variant 7 (ARv7) forms heterodimers with full-length AR (ARfl) in the nucleus. These complexes interact dynamically with DNA, influencing castration-resistant prostate cancer progression.
Area of Science:
- Molecular Biology
- Biophysics
- Cancer Research
Background:
- Androgen receptor (AR) splice variants, particularly AR splice variant 7 (ARv7), are implicated in lethal castration-resistant prostate cancer.
- ARv7 expression correlates with resistance to advanced anti-androgen therapies.
- The interaction between ARv7 and full-length AR (ARfl) is not well understood.
Purpose of the Study:
- To investigate the biophysical properties of ARfl/ARv7 heterodimers.
- To elucidate the dynamics of ARv7 and ARfl interactions in the nucleus.
- To understand how these interactions affect DNA binding and transcriptional activity.
Main Methods:
- Fluorescence resonance energy transfer (FRET) to study protein proximity and interactions.
- Fluorescence recovery after photobleaching (FRAP) to assess protein dynamics.
- Nuclear localization and DNA binding studies of AR variants.
Main Results:
- ARfl and ARv7 form stable heterodimers in the nucleus through N/C-terminal interactions.
- ARfl/ARv7 heterodimers exhibit conformational changes upon DNA binding.
- ARv7 homodimers and ARfl/ARv7 heterodimers show transient DNA binding at accessible ARfl sites.
- DNA binding dynamics are determined by individual AR monomers, not dimer composition.
Conclusions:
- ARfl/ARv7 heterodimerization is a key feature of nuclear AR signaling in prostate cancer.
- ARv7's transcriptional activity is modulated by its interaction with ARfl and DNA binding dynamics.
- These findings provide insights into the mechanisms driving castration-resistant prostate cancer.
Related Concept Videos
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Conserved Binding Sites
Single-Strand DNA Binding Proteins
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

